Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use

Diabetes Care. 2013 Dec;36(12):e204-5. doi: 10.2337/dc13-1123.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anti-Asthmatic Agents / administration & dosage
  • Anti-Asthmatic Agents / therapeutic use
  • Cromolyn Sodium / administration & dosage
  • Cromolyn Sodium / therapeutic use*
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Injections, Subcutaneous
  • Insulins / administration & dosage
  • Insulins / adverse effects*
  • Lipodystrophy / chemically induced
  • Lipodystrophy / drug therapy*
  • Male
  • Young Adult

Substances

  • Anti-Asthmatic Agents
  • Hypoglycemic Agents
  • Insulins
  • Cromolyn Sodium